Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 49 - Preparations for testing in vivo
Patents for A61K 49 - Preparations for testing in vivo (35,376)
09/2014
09/04/2014US20140248217 Methods of Identifying Xenohormetic Phenotypes and Agents
09/04/2014US20140248216 Drug delivery by carbon nanotube arrays
09/04/2014US20140248215 Uses and compositions for treatment of psoriatic arthritis
09/04/2014US20140248214 High-concentration aqueous dispersions of graphene using nonionic, biocompatible copolymers
09/04/2014US20140248213 Compositions and methods for tumor imaging and targeting by a class of organic heptamethine cyanine dyes that possess dual nuclear and near-infrared properties
09/04/2014US20140248210 Multimodal silica-based nanoparticles
09/03/2014EP2772497A1 Controlled synthesis of polyglutamates with low polydispersity and versatile architectures
09/03/2014EP2772464A2 Type zinc- phthalocyanine nanowires having enhanced water solubility and water dispersibility, composite of an -type zinc- phthalocyanine nanowire/phenothiazine, and method for preparing same
09/03/2014EP2772271A1 Nanostructure, applied device and preparation method thereof
09/02/2014US8822697 Paramagnetic polynuclear metal complex having high self-relaxation rate, preparation method thereof, and contrast medium containing same
09/02/2014US8822637 Somatostatin analogues
09/02/2014US8822162 Cyanochrome fluorophores
09/02/2014US8821838 Nanoparticulate compositions for diagnostic imaging
09/02/2014US8821837 Aqueous method of making magnetic iron oxide nanoparticles
09/02/2014US8821836 SPARC binding peptides and uses thereof
09/02/2014US8821835 Flexible and/or elastic brachytherapy seed or strand
08/2014
08/28/2014WO2014130777A1 Methods for evaluating brain-wide paravascular pathway for waste clearance function and methods for treating neurodegenerative disorders based thereon
08/28/2014US20140243664 Polymeric Nanoparticles for Ultrasound Imaging and Therapy
08/28/2014US20140243509 Near infrared fluorogen and fluorescent activating proteins for in vivo imaging and live-cell biosensing
08/28/2014US20140243502 Anticoagulation agent and uses thereof
08/28/2014US20140241996 Therapeutic nanoparticles and methods of use thereof
08/28/2014US20140241995 Micropatch for assessing chemical contact allergy
08/28/2014US20140241994 Method and system for calculating a quantification indicator for quantifying a dermal reaction on the skin of a living being
08/28/2014US20140241993 Fluorescent chlorotoxin conjugate and method for intra-operative visualization of cancer
08/28/2014US20140241992 Nanostructure, applied device and preparation method thereof
08/28/2014US20140241990 Methods of using adenosine a1 receptor activation for treating depression
08/28/2014US20140241989 Novel imaging agents, process for the preparation thereof and pharmaceutical compositions containing same
08/28/2014US20140241988 Methods and compositions for treating atrial fibrillation
08/28/2014US20140241987 Alpha-synuclein antibodies and uses thereof
08/28/2014US20140241986 Formulations of fluorinated stilbene suitable for pet imaging
08/28/2014US20140241985 Chelated PSMA Inhibitors
08/27/2014EP2768491A1 Inhibitors of arginase and their therapeutic applications
08/26/2014US8815808 Modulation of activity of neurotrophins
08/26/2014US8815804 Methods and compositions related to targeting tumors and wounds
08/26/2014US8815254 Method of detoxification
08/26/2014US8815253 Compositions for inducing immune responses
08/26/2014US8815212 Nanocarriers for imaging and therapy applications
08/26/2014US8815211 Radioactive metal-labeled anti-cadherin antibody
08/26/2014US8815210 Diagnostic composition comprising plasma cations having superior safety profile
08/26/2014CA2582252C Therapeutic use of anti-tf-antigen antibody
08/21/2014WO2014126968A1 Sulfonic esters of metal oxides and methods of their use
08/21/2014WO2014125321A1 Multimodal agents for imaging
08/21/2014WO2014125256A1 Nanoparticle delivery compositions
08/21/2014US20140235790 Carbohydrate-based compositions and methods for targeted drug delivery
08/21/2014US20140234859 Controlled platelet activation to monitor therapy of adp antagonists
08/21/2014US20140234226 Plasmonic stable fluorescence superparamagnetic iron oxide nanoparticles and a method of synthesizing the same
08/21/2014US20140234225 Method of treatment using nanoparticulate compositions having lysozyme as a surface stabilizer
08/21/2014US20140234224 Compositions and methods for molecular imaging of oxygen metabolism
08/21/2014US20140234223 Nanoemulsions and use thereof as contrast agents
08/21/2014US20140234221 Antigen-binding proteins comprising recombinant protein scaffolds
08/21/2014US20140234218 Modified variable domain molecules and methods for producing them b
08/21/2014US20140234217 Remote assembly of targeted nanoparticles using complementary oligonucleotide linkers
08/21/2014US20140234214 Methods of Treating a Tauopathy
08/21/2014US20140234210 Metal bisphosphonate nanoparticles for anti-cancer therapy and imaging and for treating bone disorders
08/20/2014EP2767532A1 Novel compound for imaging tau protein accumulated in the brain
08/20/2014EP2766051A1 Porphyrin-phospholipid conjugate microbubbles and their use as contrast agents.
08/20/2014EP2766050A1 Process for the preparation of hyperpolarized derivatives for use in mri analysis
08/20/2014EP2766049A1 Photodynamic diagnosis of abnormalities of the epithelial lining of the oesophagus with the means of a 5-ala ester
08/20/2014EP2766012A2 Compositions useful in treating nephropathy and methods for preparation of same
08/20/2014EP2765997A2 Porous nanoparticle-supported lipid bilayers (protocells) for targeted delivery including transdermal delivery of cargo and methods thereof
08/19/2014US8811721 Three-dimensional ultrasonic inspection apparatus
08/19/2014US8809531 Rhodamine dyes and conjugates
08/19/2014US8808998 Diagnostic method for atherosclerosis
08/19/2014US8808703 Compounds (cystein based lipopeptides) and compositions as TLR2 agonists used for treating infections, inflammations, respiratory diseases etc
08/19/2014US8808698 Methods for inhibition of lymphangiogenesis and tumor metastasis
08/19/2014US8808668 X-ray attenuating compositions and methods
08/19/2014US8808667 Method for generating active antibodies against a resistance antigen, antibodies obtained by said method and their uses
08/19/2014US8808666 Peptides that specifically target amyloid deposits
08/19/2014US8808665 In vivo copper-free click chemistry for delivery of therapeutic and/or diagnostic agents
08/19/2014US8808664 Lipidated glycoprotein particles and methods of use
08/19/2014US8808268 Method and composition for hyperthermally treating cells
08/19/2014CA2651285C Methods and compositions for treatment of human immunodeficiency virus infection with conjugated antibodies or antibody fragments
08/19/2014CA2490659C Humanized anti-tag-72 cc49 for diagnosis and therapy of human tumors
08/14/2014WO2014124304A1 System and method using precious-metal nanoparticle contrast agent for microwave medical imaging
08/14/2014WO2014124241A1 System and method for lung denervation
08/14/2014WO2014124225A1 Radiopaque polymers for medical devices
08/14/2014WO2014124006A1 Nanoparticles for magnetic resonance imaging tracking and methods of making and using thereof
08/14/2014WO2014123899A1 Tamper resistant pharmaceutical formulations
08/14/2014WO2014123418A1 Groundbreaking platform technology for specific binding to necrotic cells
08/14/2014WO2014122608A1 Nanoparticle having a magnetic core, polymer coating and gold shell, and method for its synthesis
08/14/2014WO2014122431A1 Biospecific agents for bone
08/14/2014WO2014122228A1 Labelled compounds that bind to alpha-v-beta-3 integrin
08/14/2014WO2014121819A1 Folate functionalized nanodiamond particles, method for its preparation and their use
08/14/2014WO2014100380A3 Multimodal particles, methods and uses thereof
08/14/2014US20140228552 Mri contrast enhancing agent
08/14/2014US20140227315 Novel Chimeric Proteins and Methods for Using The Same
08/14/2014US20140227196 Porphyrin compounds and their use as mri contrast agents
08/14/2014US20140227195 Complex and contrast agent for photoimaging using the same
08/14/2014US20140227194 Preparation for Restenosis Prevention
08/14/2014US20140227193 Preparation for Restenosis Prevention
08/14/2014US20140227192 Preparation for Restenosis Prevention
08/14/2014US20140227191 L-glutamic acid and l-glutamine derivative (iii), use thereof and method for obtaining them
08/14/2014US20140227189 Method and apparatus for kidney function analysis
08/14/2014US20140227188 Compositions and Methods for Using Cathepsin E Cleavable Substrates
08/14/2014US20140227187 Sulfonic Esters Of Metal Oxides And Methods Of Their Use
08/14/2014US20140227186 Nanoparticle delivery compositions
08/14/2014US20140227185 Glutathione-based drug delivery system
08/14/2014US20140227182 Cancer imaging with therapy: theranostics
08/14/2014US20140227179 Anti-mucin antibodies for early detection and treatment of pancreatic cancer
08/14/2014US20140227177 Scanning Suspension Comprising a Particle with a Diameter of at least 1 Micrometer
1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 ... 354